News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Arpida Acquires Combio A/S Through All-Share Deal, Brings In CHF33 Million (US$26.8 Million)
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Arpida Ltd. acquired its erstwhile partner Combio A/S in an all-stock transaction that will boost its chemistry capabilities and expand its head count from 47 to 73 employees.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
People
MORE ON THIS TOPIC
Mergers & acquisitions
UCB elevates epilepsy expertise with up to $1.15B Neurona takeover
April 20, 2026
·
2 min read
·
Tristan Manalac
CDC
Trump nominates new CDC director, appoints various leaders to embattled agency
April 16, 2026
·
2 min read
·
Heather McKenzie
Gene therapy
MeiraGTx, spying hope in a failed trial, buys back eye disease gene therapy from J&J
April 16, 2026
·
2 min read
·
Annalee Armstrong
Deals
Obesity’s explosive growth continues as Q1 deals exceed total 2025 value
April 16, 2026
·
2 min read
·
Tristan Manalac